Status
Conditions
About
It is only between peak viremia and viral setpoint in natural acute HIV-1 infection that the immune response overwhelms viral replication resulting in a plasma viral load decline. The aim will be to characterize these immune responses, how they develop and their progeny. This will require the need to identify HIV-1 infected individuals before peak viremia and follow them to post viral setpoint.
This protocol describes a pilot study to evaluate the feasibility of identifying, enrolling and following acute and early HIV-1 infected individuals from voluntary counselling and testing centres in Masaka, Bukomansimbi, Kalungu, Lwengo, Sembababule and Lyantonde districts.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Has any condition that in the opinion of the principal investigator or designee, would preclude provision of informed consent, or otherwise interfere with achieving the study objectives.
Loading...
Central trial contact
ANDREW OBUKU, PhD; FREDDIE KIBENGO, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal